Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Sartorius AG    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SARTORIUS VORZUEGE : From a Buy to Neutral rating by Warburg Research

07/22/2020 | 05:16am EST

Warburg Research decreases his rating from Neutral to Sell. The target price is reviewed upwards from EUR 300 to EUR 330.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
SARTORIUS AG 1.78% 343 Delayed Quote.-0.58%
SARTORIUS STEDIM BIOTECH 2.30% 329.8 Real-time Quote.13.26%
All news about SARTORIUS AG
01/21SARTORIUS : Stedim Biotech's $1.5 million donation creates cell...
PU
01/21SARTORIUS VORZUEGE : JP Morgan reaffirms its Buy rating
MD
01/15SARTORIUS : Partners With RoosterBio to Advance Cell and Gene Therapy Manufactur..
PU
01/06SARTORIUS : to acquire Novasep's chromatography process equipment...
PU
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 -2-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -3-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -2-
DJ
01/04SARTORIUS VORZUEGE : Receives a Buy rating from JP Morgan
MD
01/04SARTORIUS STEDIM BIOTECH SA : Declaration relative to the number of shares and v..
DJ
2020SARTORIUS : and Evotec Partner With Start-up Curexsys on IPSC-Based...
PU
More news
Financials
Sales 2020 2 305 M 2 805 M 2 805 M
Net income 2020 233 M 284 M 284 M
Net Debt 2020 1 759 M 2 140 M 2 140 M
P/E ratio 2020 113x
Yield 2020 0,23%
Capitalization 24 824 M 30 218 M 30 209 M
EV / Sales 2020 11,5x
EV / Sales 2021 9,68x
Nbr of Employees 10 008
Free-Float 46,8%
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 246,58 €
Last Close Price 343,00 €
Spread / Highest target 2,33%
Spread / Average Target -28,1%
Spread / Lowest Target -80,0%
EPS Revisions
Managers and Directors
NameTitle
Joachim Kreuzburg Chief Executive Officer
Lothar Kappich Chairman-Supervisory Board
Volker Niebel Head-Production, Procurement & Business Operations
Rainer Lehmann Chief Financial Officer
Oscar-Werner Reif Head-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SARTORIUS AG-0.58%30 218
REVENIO GROUP OYJ-0.80%1 611
ALPHATEC HOLDINGS, INC.2.00%1 161
CELLAVISION AB (PUBL)3.06%910
VAREX IMAGING CORPORATION21.52%794
OXFORD IMMUNOTEC GLOBAL PLC25.39%560